Hm Payson & CO Catalent, Inc. Transaction History

Hm Payson & CO

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 12, 2022	SELL	$94.19 - $124.49 $3,955 - $5,228	-42 Closed	0 $0
Q2 2021 Aug 17, 2021	SELL	$100.34 - $115.69 $15,051 - $17,353	-150 Reduced 78.13%	42 $5,000
Q1 2021 Jun 15, 2021	SELL	$101.51 - $125.27 $10,151 - $12,527	-100 Reduced 34.25%	192 $20,000
Q3 2020 Dec 21, 2020	BUY	$72.74 - $92.5 $21,240 - $27,010	292 New	292 $25,000

514

149M

575K

2.03M

Ticker CTLT
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 179,896,000
Market Cap $11.4B
Description
Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...

Get notified when there are updates to the investment portfolio of Hm Payson & CO, based on Form 13F filings with the SEC.

Stay updated on Hm Payson & CO with notifications on news.